![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2017
Provencio Pulla, M.; Santoro, A.; Mollica, L.; Leppa, S.; Follows, G.; Lenz, G.; Kim, W. S.; Nagler, A.; Panayiotidis, P.; Demeter, J.; Ozcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Ishida, T.; Huang, L.; Garcia-Vargas, J.; Childs, B. H.; Zinzani, P. L. und Dreyling, M.
(2017):
Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study.
In: Annals of Oncology, Bd. 28
Zinzani, P. L.; Santoro, A.; Leppa, S.; Demeter, J.; Follows, G. A.; Lenz, G.; Kim, W. S.; Mollica, L.; Nagler, A.; Diong, C. P.; Provenciio, M.; Stevens, D. A.; Trevarthen, D.; Maagnoli, M.; Cupit, L.; Yin, S.; Hiemeyer, F.; Garcia-Vargas, J.; Childs, B. H. und Dreyling, M.
(2017):
Efficacy and safety of Copanlisib in patients with relapsed/refractory follicular lymphoma: a subset analysis of the Chronos-1 study.
In: Haematologica, Bd. 102: S. 314-315
Dreyling, M.; Santoro, A.; Mollica, L.; Leppa, S.; Follows, G. A.; Lenz, G.; Kim, W. S.; Nagler, A.; Panayiotidis, P.; Demeter, J.; Ozcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Stevens, D. A.; Trevarthen, D.; Giurescu, M.; Kupit, L.; Childs, B. H. und Zinzani, P. L.
(2017):
Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study.
In: Oncology Research and Treatment, Bd. 40: S. 12
Angenendt, L.; Bormann, E.; Braun, L.; Mikesch, J.-H.; Herold, T.; Metzeler, K.; Bohlander, S.; Görlich, D.; Arteaga, M. F.; Wörmann, B. J.; Lenz, G.; Müller-Tidow, C.; Hiddemann, W.; Spiekermann, K.; Krug, U.; Sauerland, M. C.; Berdel, W. E. und Schliemann, C.
(2017):
Calcitonin Receptor-like (CALCRL) expression predicts poor survival in acute myeloid leukemia.
In: Oncology Research and Treatment, Bd. 40: S. 27
2016
Lenz, G.; Balasubramanian, S.; Goldberg, J.; Rizo, A.; Schaffer, M.; Phelps, C.; Rule, S. und Dreyling, M.
(2016):
Sequence variants in patients with primary and acquired resistance to Ibrutinib in the phase 3 MCL3001 (RAY) trial.
In: Haematologica, Bd. 101: S. 155
2005
Lenz, G.; Dreyling, Martin; Hoster, Eva; Wörmann, Bernhard; Dührsen, U.; Metzner, B.; Eimermacher, H.; Neubauer, A.; Wandt, H.; Steinhauer, H.; Martin, S.; Heidemann, E.; Aldaoud, A.; Parwaresch, R.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
In: Journal of Clinical Oncology, Bd. 23, Nr. 23: S. 1984-1992
Dreyling, Martin; Lenz, G.; Hoster, Eva; Van-Hoof, A.; Gisselbrecht, C.; Schmits, R.; Metzner, B.; Truemper, L.; Reiser, M.; Steinhauer, H.; Boiron, J. M.; Boogaerts, M. A.; Aldaoud, A.; Silingardi, V.; Kluin-Nelemans, H. C.; Hasford, Joerg; Parwaresch, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
In: Blood, Bd. 105, Nr. 7: S. 2677-2684
2004
Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Forstpointner, R.; Wandt, H.; Freund, M.; Hess, G.; Truemper, L.; Diehl, V.; Kropff, M.; Kneba, M.; Schmitz, N.; Metzner, B.; Pfirrmann, Markus; Unterhalt, Michael und Hiddemann, Wolfgang
(2004):
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
In: Blood, Bd. 104, Nr. 9: S. 2667-2674
Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Haferlach, T.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2004):
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
In: Journal of Clinical Oncology, Bd. 22, Nr. 24: S. 4926-4933
Wirth, A.; Baethmann, A.; Schlesinger-Raab, Anne; Assal, J.; Aydemir, S.; Bayeff-Filloff, M.; Beck, J.; Belg, A.; Boscher, A.; Chapuis, D.; Dietz, H. G.; Doffinger, J.; Eisenmenger, Wolfgang; Gerstner, W.; Gobel, W. E.; Grosse, P.; Grumme, T.; Gutermuth, L.; Hölzel, Dieter; Hopner, F.; Huf, R.; Jaksche, H.; Jensen, U.; Kettemann, M.; Ketterl, R.; Kirmayer, U.; Kolodziejcyk, D.; Kostler, W.; Kuznik, J.; Lackner, C.; Lenz, G.; Lochbihler, H.; Lumenta, C.; Martin, S.; Preisz, A.; Prokscha, G.; Regel, G.; Reischl, H.; Reulen, H. J.; Rothmeier, F.; Sackerer, D.; Schneck, S.; Schweiberer, L.; Sommer, F.; Steiger, H. J.; Stolpe, E.; Stummer, W.; Tanner, P.; Trappe, A.; Twickel, J.; Üblacker, P.; Wambach, W.; Wengert, P. und Zimmerer, S.
(2004):
Prospective documentation and analysis of the pre- and early clinical management in severe head injury in southern Bavaria at a population based level.
In: Acta Neurochirurgica / Supplements, Bd. 89: S. 119-123